BMI1 and hepatocellular carcinoma: In this research work, we provide strong clinical data showing that in HCC, high expression level of BMI1 and/or TIC-related gene/protein signature associates with worse prognosis and increased BDTT incidence in a comparatively large patient cohort, implying the possible role of BMI1high TICs on HCC development and progression.